Febrile seizures Sanaa - yns-yemen.com
Transcript of Febrile seizures Sanaa - yns-yemen.com
Febrile seizures
Olivier Dulac
Hôpital Necker-Enfants Malades,
Université Paris V, INSERM U663
Definition
• Seizures precipitated by fever that is not
due to an intracranial infection or other
definable CNS cause
• They result from
– Fever
– Immature brain
– Genetic predisposition
Incidence
• The most common type of seizures in the
pediatric age group
• They affect 2 to 5% of children aging three
months to five years
• 2 to 10% develop subsequent unprovoked
seizures
• About one-third of all children with a first
febrile seizure will experience recurrent
Clinical manifestations
• Febrile seizures are
– Tonic / clonic
– Hypotonic (syncope?)
– Uni- or bilateral
• Not as myoclonus, spasms, or non convulsive
• Distinguish:
– Simple Febrile : generalized, <15 minutes, single
– Complex seizures: partial, >15 minutes, repeated
Risk
• Unilateral seizures may be followed by a Todd hemiplegia lasting a few hours, rarely several days
• The incidence of Todd hemiplegia is probably in the range of 0.4% of all cases of FS
• If lasting hours, seizure may be first stage of HH (hemiconvulsion – hemiplegic) syndrome
A possible mechanism for
HH syndrome?
Epileptic
activityCytokines?
Cell
Death
+
Network
reorganization
Viral
infection
triggering
factor
Callosal maturation permits bilateral involvement
Pathways between mesial temporal
and neocortical structures
1) infant 2) adolescent
Neocortical dysplasia Hippocampal atrophy
Temporal lobe epilepsy :
A model to distinguish
semantic and episodic memories
0 5 10 20years
Semantic
abilities
learning
Episodic
memory
ChildAdolescent
Investigations in FS
• Lumbar punction for children under 12 months with first seizure, to exclude:
– Bacterial meinigitis
– Herpetic encephalitis• Seizures affect one side of the face
• On 2nd/3rd day of fever
• CSF, MRI not reliable� begin with Aciclovir ®
• Blood glucose (hypoglycaemia), calcium
• + Viral investigations
Infectious aetiology• Viruses are responsible for precipitating illness in 90% of cases– Herpes virus 6 (Roseola Infantum) and 7 may be responsible for triggering febrile seizures
– Rotavirus infection have been also associated with encephalopathic manifestations
• Bacterial infections less commonly cause FS
• The incidence of febrile seizures with shigellosis is about 19.7%
• Fever resulting from immunization can provoke febrile seizures.– Prognosis seems favorable in most cases.
– Mainly with pertussis (wdpt not dtap) and measles vaccines.
Risk of recurrence
• Early age at onset (< 12 months)
• Family history of febrile seizures or epilepsy
• Epilepsy or febrile seizures in a first degree
relative
• Short duration between 2 fits < 3 months
• Relatively low fever at time of first seizure
• Brief duration between fever onset and initial
seizure
+ (possible)+Attendance at day care
+Duration of illness before
seizure
+Level of temperature at first
seizure
+Age of onset <18 months
-+Developmental delay or
neurological problems.
++Family history febrile seizures
in a first degree relative
Predicting
recurrence after a
first febrile seizure
Predicting a first
febrile seizure
Genetic factors
• FS occur with increase frequency among family members of patients with FS
• Most studies suggest a dominant mode of inheritance with reduced penetrance and variable expression
• Six loci of FS susceptibility :
– 8q 13-q21 (FEB1),
– 19 q (FEB2),
– 2q23-q24 (FEB3),
– 5q14-q15 (FEB4),
– 6q22-q24,
– 18q11
Risk of epilepsy following FS
• Non febrile seizures following febrile convulsions occur in 2% - 7% of patients
• Risk for generalized epilepsy is increased by:– Positive family history of non febrile seizures
– Large number of brief generalized febrile seizures
• Risk for partial epilepsy:– Prolonged lateralized febrile seizures.
– Early age at onset of febrile seizures and persisting neurologic dysfunction
– MRI studies have shown frequent evidence of hippocampal atrophy and mesial temporal sclerosis in patients with intractable temporal lobe epilepsy and history of prolonged febrile seizures
Epilepsy syndromes following
febrile seizures
• Absence epilepsy in 15% -25% of children with history of FS
• The incidence of FS in patients with Benign Rolandic epilepsy ranges from 9% to 20% which clearly is in excess of its incidence in the general population.
• Myoclonic absences
• Juvenile myoclonic epilepsy
Have been observed to follow FCs
Febrile seizures +
• FS usually with multiple recurrences, that recur
after the age of 6 years, and often associated
with non febrile generalized seizures (Scheffer
and Berkovic 1997).
• Dominant transmission termed as GEFS+ to.
• Missense mutations in the pore-forming subunit
– sodium channel subunit (SCN1B, SCN1A, and
SCN2A)
– defect in the gamma 2 subunit of GABA receptor
Dravet syndrome
• At the severe end of the GEFS+ spectrum is
Severe Myoclonic Epilepsy of infancy (SMEI,
Dravet syndrome):
– Onset in the 1st year of life
– Unilateral (alternating sides) and generalized
– Clonic
– With mild fever
– Myoclonus and SW occurring after age 3 years
• Families in which both Dravet syndrome and
GEFS+ presented in different individuals have
been reported
Treatment of FS
Three main issues are especially important
for the treatment:
– febrile seizures are extremely upsetting
for the parents
– the recurrence rate is 30-40%
– the febrile status occurs unpredictably
and is potentially damaging to the CNS
Acute management
• Control of the ongoing seizure
• Treatment of the fever preferably with
external cooling and paracetamol
• Treatment of the underlying illness
Management of continuing seizure
• Placement in the recovery semi-prone lateral position
• Adequate airway should be maintained
• Benzodiazepines, usually diazepam is the first choice:
– rectally in solution at seizure onset 0.5mg/kg/dose
– or intravenously 0.3 mg/kg/dose
– or midazolam buccally
• Seizures are controlled more quickly with intravenous
diazepam than with intranasal midazolam, although
midazolam is as safe as diazepam
Prophylaxis of recurrence
• Two types of prophylactic treatment :
– Intermittent prophylaxis given at the first sign
of a febrile illness (0.3 mg/kg/dose
Diazepam t.d.s)
– Continuous prophylaxis by administering
daily anticonvulsant drugs
Continuous prophylaxis
• Children with high risk for recurrence are good candidates
(complex FS or onset before 1 year of life)
• Usually maintained for 1 year :
– a vast majority of recurrences take place within 1 year of the first seizure
– severe seizures occur mainly in younger infants
• Phenobarbitone (3 mg/kg/d) � blood level of around 15 µg
• Sodium valproate reduces recurrences by about two-thirds
Side effects of
continuous prophylaxis
• Acute poisoning in the child or siblings
• Abrupt discontinuation provoking seizures
• The interactions with other medications
• The interference with calcium-phosphorus
metabolism
• Phenobarbital side effect on behavior and I.Q
Conclusions
• Differencial diagnosis: bacterial meningitis, viral encephalitis
• Distinguish simple/complicated FS
• Risk factors: HH syndrome, Dravet syndrome, mesial temporal lobe epilepsy
• Treatment restricted to complicated/earlyonset FS
– Intermittent (benzodiazepine)
– And/or continuous (valproate)
Stiripentol in Dravet syndromeDouble blind, multicentric
• % Responders
• Seizure frequency
• Seizure cessation
Placebo Stiripentol p
5% 71% <2.10-5
14/mths 6.5/mths <0.05
0 9
20
21
Placebo
Stiripentol
Treatment of Dravet syndrome
• Avoid carbamazepine, phenobarbital, phenytoin, vigabatrin and lamotrigine
• Valproate after the first seizure (complex, first year of life)
• Preventive treatment of seizures in case of fever, with diazepam
• Clobazam and Stiripentol are added afterthe first prolonged seizure or repeatseizures